Pre-treating human NK cells with dasatinib increases cytotoxicity against resistant Daudi but not sensitive K562 or Jurkat cells - An example for differential immunomodulation

被引：0
|
作者：
Hassold, N. [1 ]
Seystahl, K. [1 ]
Dix, C. [1 ]
Wischhusen, J. [1 ]
Einsele, H. [1 ]
Seggewiss, R. [1 ]
机构：
[1] Univ Wurzburg, Wurzburg, Germany
来源：
BONE MARROW TRANSPLANTATION | 2009年 / 43卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S267 / S268
页数：2
相关论文
共 30 条
  • [21] Differential effects of peroxisome proliferator-activated receptor agonists on doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells
    Yousefi, B.
    Samadi, N.
    Baradaran, B.
    Rameshknia, V.
    Shafiei-Irannejad, V.
    Majidinia, M.
    Targhaze, N.
    Zarghami, N.
    CELLULAR AND MOLECULAR BIOLOGY, 2015, 61 (08) : 118 - 122
  • [22] A differential assay of NK-cell-mediated cytotoxicity in K562 cells revealing three sequential membrane impairment steps using three-color flow-cytometry
    Kasatori, N
    Ishikawa, F
    Ueyama, M
    Urayama, T
    JOURNAL OF IMMUNOLOGICAL METHODS, 2005, 307 (1-2) : 41 - 53
  • [23] Comparative cytotoxicity of 2,3,9-trimethoxypterocarpan in leukemia cell lines (HL-60, Jurkat, Molt-4, and K562) and human peripheral blood mononuclear cells
    Militao, Gardenia C. G.
    Bezerra, Daniel P.
    Pessoa, Claudia
    de Moraes, Manoel Odorico
    da Ponte, Flavio A. F.
    Lima, Mary Anne S.
    Silveira, Edilberto R.
    Costa-Lotufo, Leticia V.
    JOURNAL OF NATURAL MEDICINES, 2007, 61 (02) : 196 - 199
  • [24] Comparative cytotoxicity of 2,3,9-trimethoxypterocarpan in leukemia cell lines (HL-60, Jurkat, Molt-4, and K562) and human peripheral blood mononuclear cells
    Gardenia C. G. Militão
    Daniel P. Bezerra
    Claudia Pessoa
    Manoel Odorico de Moraes
    Flavio A. F. da Ponte
    Mary Anne S. Lima
    Edilberto R. Silveira
    Letícia V. Costa-Lotufo
    Journal of Natural Medicines, 2007, 61 : 196 - 199
  • [25] EFFECTS OF NUCLEOTIDES ON VP-16-INDUCED DNA DAMAGE IN NUCLEI FROM HUMAN-LEUKEMIA K562 CELLS SENSITIVE AND RESISTANT TO VP-16
    YALOWICH, JC
    BENTON, S
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 317 - 317
  • [26] LAK-CELL-MEDIATED CYTOTOXICITY AGAINST TUMOR-CELL TARGETS USED TO MONITOR THE STIMULATORY EFFECT OF INTERLEUKIN-2 - CYTOTOXICITY, TARGET RECOGNITION AND PHENOTYPE OF EFFECTOR-CELLS LYSING THE DAUDI, T24 AND K562 TUMOR-CELL LINES
    HERMANN, GG
    ZEUTHEN, J
    CLAESSON, MH
    NATURAL IMMUNITY, 1992, 11 (01) : 7 - 16
  • [27] Exogenous and endogenous nitric oxide (NO center dot) protects against tert-butyl hydroperoxide (TBH)-induced cytotoxicity in human leukemia K562 cells: Role of intra-cellular hemoglobin (Hb).
    Yalowich, JC
    Allan, WP
    Mawhinney, BJ
    Akano, R
    Thampatty, P
    Kozlov, A
    Kagan, VE
    FASEB JOURNAL, 1996, 10 (03): : 4071 - 4071
  • [28] VEGF165b augments NK92 cytolytic activity against human K562 leukemia cells by upregulating the levels of perforin and granzyme B via the VEGR1-PLC pathway
    Wang Xiaoyin
    Liang Chen
    Xia Wenjiao
    Guo Changjiang
    Niu Zhiyuan
    Zhu Wuling
    Zhang Huiyong
    MOLECULAR IMMUNOLOGY, 2020, 128 : 41 - 46
  • [29] Activation of Human T-Helper/Inducer Cell, T-Cytotoxic Cell, B-Cell, and Natural Killer (NK)-Cells and induction of Natural Killer Cell Activity against K562 Chronic Myeloid Leukemia Cells with Modified Citrus Pectin
    Ramachandran, Cheppail
    Wilk, Barry J.
    Hotchkiss, Arland
    Chau, Hoa
    Eliaz, Isaac
    Melnick, Steven J.
    BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2011, 11
  • [30] Activation of Human T-Helper/Inducer Cell, T-Cytotoxic Cell, B-Cell, and Natural Killer (NK)-Cells and induction of Natural Killer Cell Activity against K562 Chronic Myeloid Leukemia Cells with Modified Citrus Pectin
    Cheppail Ramachandran
    Barry J Wilk
    Arland Hotchkiss
    Hoa Chau
    Isaac Eliaz
    Steven J Melnick
    BMC Complementary and Alternative Medicine, 11
123